Stereotactic Body Radiation Therapy For Early-Stage Non-Small Cell Lung Cancer

Publication Date: October 1, 2017
Last Updated: March 14, 2022

Recommendations

When is SBRT appropriate for patients with T1-2, N0 NSCLC who are medically operable?

Any patient with operable stage I NSCLC being considered for SBRT should be evaluated by a thoracic surgeon, preferably in a multidisciplinary setting, to reduce specialty bias. (Strong, Moderate)
323259

Overview

Title

Stereotactic Body Radiation Therapy For Early-Stage Non-Small Cell Lung Cancer

Authoring Organization